Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 5/2009

01-05-2009 | Review

Rat Models for Bariatric Surgery and Surgery for Type 2 Diabetes Mellitus

Authors: Sheetal Bharat Mistry, Juan J. Omana, Subhash Kini

Published in: Obesity Surgery | Issue 5/2009

Login to get access

Abstract

Type 2 diabetes mellitus being one of the most prevalent diseases in the world has led to a variety of research using animal models. This review focuses on various rat models to study the effect that surgical procedures have on type 2 diabetes mellitus and obesity. Rat models can be classified as Obese Diabetic, Non-Obese Diabetic, Obese Non-Diabetic, and Non-Obese Non-Diabetic. Here, we have discussed the particular characteristics of each rat so that it can provide the appropriate model to study different pathological processes involve in type 2 Diabetes and obesity.
Literature
1.
Pories WJ, Swanson MS, Macdonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222(3):339–50.CrossRef
2.
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238(4):467–84.PubMedPubMedCentral
3.
Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996;119(3):261–8.CrossRef
4.
Etgen GJ, Oldham BA. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 2000;49(5):684–8.CrossRef
5.
Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998;47(3):358–64.CrossRef
6.
Corsetti JP, Sparks JD, Peterson RG, et al. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 2000;148(2):231–41.CrossRef
7.
Rubino F, Zizzari P, Tomasetto C, et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 2005;146(4):1745–51.CrossRef
8.
Pereferrer FS, Gonzalez MH, Rovira AF, et al. Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg 2008;18(1):97–108.CrossRef
9.
Baly DL, Zarnowski MJ, Carswell N, et al. Insulin resistant glucose transport activity in adipose cells from the SHR/N-corpulent rat. J Nutr 1989;119(4):628–32.CrossRef
10.
Velasque MT, Bhathena SJ, Hansen CT. Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus. Int J Exp Diabetes Res 2001;2(3):217–23.CrossRef
11.
Amy RM, Dolphin PJ, Pederson RA, et al. Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent. Atherosclerosis 1988;69(2–3):199–209.CrossRef
12.
Russell JC, Graham S, Hameed M. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 1994;43(5):538–43.CrossRef
13.
Clark TA, Pierce GN. Cardiovascular complications of non-insulin-dependent diabetes: the JCR:LA-cp rat. J Pharmacol Toxicol Methods 2000;43(1):1–10.CrossRef
14.
Kawano K, Hirashima T, Mori S, et al. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 1994;24(Suppl):S317–S320.CrossRef
15.
Zhu M, Noma Y, Mizuno A, et al. Poor capacity for proliferation of pancreatic beta-cells in Otsuka–Long–Evans–Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes 1996;45(7):941–6.CrossRef
16.
Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976;119(1):85–90.CrossRef
17.
Portha B, Giroix MH, Serradas P, et al. beta-cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony. Diabetes 2001;50(Suppl 1):S89–S93.CrossRef
18.
Picarel-Blanchot F, Berthelier C, Bailbe D, et al. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat. Am J Physiol 1996;271(4 Pt 1):E755–E762.PubMed
19.
Miralles F, Portha B. Early development of beta-cells is impaired in the GK rat model of type 2 diabetes. Diabetes 2001;50(Suppl 1):S84–S88.CrossRef
20.
Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 2005;21(6):495–504.CrossRef
21.
Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto–Kakizaki rats. Am J Surg 2007;194(2):221–4.CrossRef
22.
Wang TT, Hu SY, Gao HD, et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 2008;247(6):968–75.CrossRef
23.
Patriti A, Aisa MC, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery 2007;142(1):74–85.CrossRef
24.
Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244(5):741–9.CrossRef
25.
Weksler-Zangen S, Yagil C, Zangen DH, et al. The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences. Diabetes 2001;50(11):2521–9.CrossRef
26.
Shinohara M, Masuyama T, Shoda T, et al. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 2000;1(2):89–100.CrossRef
27.
Masuyama T, Fuse M, Yokoi N, et al. Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat. Biochem Biophys Res Commun 2003;304(1):196–206.CrossRef
28.
Shinohara M, Oikawa T, Sato K, et al. Glucose intolerance and hyperlipidemia prior to diabetes onset in female Spontaneously Diabetic Torii (SDT) rats. Exp Diabesity Res 2004;5(4):253–6.CrossRef
29.
Shimoike T, Yanase T, Umeda F, et al. Subcutaneous or visceral adipose tissue expression of the PPARgamma gene is not altered in the fatty (fa/fa) Zucker rat. Metabolism 1998;47(12):1494–8.CrossRef
30.
Oana F, Takeda H, Hayakawa K, et al. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism 2005;54(8):995–1001.CrossRef
31.
Young EA, Taylor MM, Taylor MK, et al. Gastric stapling for morbid obesity: gastrointestinal response in a rat model. Am J Clin Nutr 1984;40(2):293–302.CrossRef
32.
Xu Y, Ohinata K, Meguid MM, et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002;107(1):56–63.CrossRef
33.
Endo Y, Ohta M, Kai S, et al. An obese rat model of bariatric surgery with gastric banding. Obes Surg 2007;17(6):815–9.CrossRef
34.
Chen DC, Stern JS, Atkinson RL. Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats. Am J Physiol 1990;258(1 Pt 2):R269–R273.PubMed
35.
Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999;9(3):223–8.CrossRef
36.
Levin BE, Dunn-Meynell AA, Balkan B, et al. Selective breeding for diet-induced obesity and resistance in Sprague–Dawley rats. Am J Physiol 1997;273(2 Pt 2):R725–R730.PubMed
37.
Aprahamian CJ, Tekant G, Chen M, et al. A rat model of childhood diet-induced obesity: Roux-en-Y gastric bypass induced changes in metabolic parameters and gastric peptide ghrelin. Pediatr Surg Int 2007;23(7):653–7.CrossRef
38.
Levin BE, Sullivan AC. Glucose-induced sympathetic activation in obesity-prone and resistant rats. Int J Obes 1989;13(2):235–46.PubMed
39.
Meguid MM, Ramos EJ, Suzuki S, et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg 2004;8(5):621–30.CrossRef
40.
Romanova IV, Ramos EJ, Xu Y, et al. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg 2004;199(6):887–95.CrossRef
41.
de Campos Martins MV, Peixoto AA, Schanaider A, et al. Glucose tolerance in the proximal versus the distal small bowel in wistar rats. Obes Surg 2008;19(2):202–6.CrossRef
42.
Estadella D, Oyama LM, Damaso AR, et al. Effect of palatable hyperlipidic diet on lipid metabolism of sedentary and exercised rats. Nutrition 2004;20(2):218–24.CrossRef
43.
Prada PO, Zecchin HG, Gasparetti AL, et al. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 2005;146(3):1576–87.CrossRef
44.
Monteiro MP, Monteiro JD, Aguas AP, et al. A rat model of restrictive bariatric surgery with gastric banding. Obes Surg 2006;16(1):48–51.CrossRef
45.
le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243(1):108–14.CrossRef
46.
Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239(1):1–11.CrossRef
47.
Patriti A, Facchiano E, Sanna A, et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004;14(6):840–8.CrossRef
48.
Patriti A, Facchiano E, Donini A. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;240(2):388–9.CrossRef
49.
Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89(6):2608–15.CrossRef
50.
Valverde I, Puente J, Martin-Duce A, et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 2005;15(3):387–97.CrossRef
Metadata
Title
Rat Models for Bariatric Surgery and Surgery for Type 2 Diabetes Mellitus
Authors
Sheetal Bharat Mistry
Juan J. Omana
Subhash Kini
Publication date
01-05-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 5/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-9811-0

Other articles of this Issue 5/2009

Obesity Surgery 5/2009 Go to the issue

Research Article

A Rodent Model of Adjustable Gastric Band Surgery—Implications for the Understanding of Underlying Mechanisms

Research Article

Parameters of Inflammation in Morbid Obesity: Lack of Effect of Moderate Weight Loss

Research Article

Vitamin D Status Before Roux-en-Y and Efficacy of Prophylactic and Therapeutic Doses of Vitamin D in Patients After Roux-en-Y Gastric Bypass Surgery

Case Report

After 3 Years of Starvation: Duodenum Swallowed Remaining Stomach

Letter to the Editor

Letter to Editor REPLY—Response to Prof. Schiemann’s Letter

Erratum

Erratum to: Rhabdomyolysis After Sleeve Gastrectomy: Increase in Muscle Enzymes Does not Predict Fatal Outcome